Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $829.12M.
ENTERPRISE VALUE (EV)
$829.12M
Odyssey Therapeutics, Inc.
Market Cap
$870.81M
Enterprise Value (EV)
$829.12M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Odyssey Therapeutics, Inc. (ODTX) | $870.81M | $829.12M |
| SI-BONE, Inc. (SIBN)vs › | $867.03M | $841.07M |
| QuidelOrtho Corporation (QDEL)vs › | $857.16M | $3.81B |
| Arbutus Biopharma Corp (ABUS)vs › | $884.97M | $869.42M |
| Alumis Inc. (ALMS)vs › | $855.38M | $828.11M |
| Bioventus Inc. (BVS)vs › | $887.50M | $1.12B |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $887.99M | $869.82M |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $853.13M | $832.27M |
| SL Science Holding Ltd (SLBT)vs › | $852.35M | $851.31M |
| Pacific Biosciences of California, Inc. (PACB)vs › | $838.62M | $1.48B |
Market Cap
$870.81M
Total Debt
$0.00
Cash
$41.69M
Enterprise Value
$829.12M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
